Cite
HARVARD Citation
Uchida, T. et al. (2019). Different incidence of interstitial lung disease according to different kinds of EGFR‐tyrosine kinase inhibitors administered immediately before and/or after anti‐PD‐1 antibodies in lung cancer. Thoracic cancer. 10 (4), pp. 975-979. [Online].